R

Remix Therapeutics

Biotech firm developing mRNA-degrading therapies

Senior Director - GCP Quality

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeWatertown, MA, USAIn-person

About the Job

Requirements

  • A Bachelor of Science degree in a life science is required.
  • At least 10 years of direct GCP pharmaceutical or biotechnology experience.
  • Solid understanding and application of GCP, GLP, and ICH requirements, especially ICH E6.
  • Excellent written and oral communication skills.
  • A well-organized, self-motivated, and independent work style, with the ability to initiate and follow through on assignments.
  • Interpersonal skills, including knowledge of basic negotiation, influencing, and conflict management, to assure effective interactions within and across departments.
  • Ability to handle multiple project issues simultaneously while managing time demands, incomplete information, or unexpected events.
  • Understanding of drug and biologic development and clinical research processes.
  • General understanding of non-clinical research and manufacturing processes, including terminology.
  • Ability to travel domestically and internationally.

Responsibilities

  • Write and/or review standard operating procedures to assess consistency and compliance with regulatory requirements and internal standards, and determine and ensure effective implementation across the organization.
  • Provide guidance to Clinical Operations staff and other applicable GCP-related departments based on interpretation of current regulations to ensure best practices, including risk-based management.
  • Guide the identification and management of risks in clinical trial activities, and monitor and evaluate risk management activities.
  • Work with Clinical Operations and other applicable GCP-related departments to ensure and coordinate timely, appropriate, and complete resolution of findings and non-compliant issues, including approval of corrective and preventive action plans as necessary.
  • Participate in the review of drug safety practices for clinical trial compliance.
  • Conduct and/or assist in internal audits of systems, processes, vendors, and computer system validation.
  • Identify the need for, conduct, and/or assist in external audits, including investigator sites, central institutional review boards, contract research organizations, and clinical laboratories.
  • Oversee the audit response process for investigator site and contract research organization audits and inspections, and ensure that actions addressing findings are acceptable through the corrective and preventive action process.
  • Provide functional review of clinical protocols, informed consent forms, clinical study reports, and other clinical trial-related documents.
  • Assist and advise with training quality assurance and clinical staff as necessary for GCP.
  • Collaborate with applicable departmental heads to identify clinical trial and regulatory training needs for Clinical Operations and other clinical trial members based on regulatory changes, process or system changes, audit findings, and trends, and assist in coordinating training to meet those needs.
  • Identify potential systemic gaps and coordinate with appropriate stakeholders to ensure timely remediation; escalate critical non-compliance or lack of urgency in remediation to senior management as appropriate.
  • Perform program-specific root cause analysis of compliance issues and provide metrics for tracking and trending for overall quality assurance reporting requirements to functional and senior management.
  • Guide the development and management of key vendor oversight activities for clinical trials, and monitor and evaluate oversight activities.
  • Assist senior staff during regulatory inspections.
  • Perform other duties as required.

Desired Qualifications

  • Broad experience in product development, clinical operations, regulatory compliance, and GCP auditing.

About the Company

Remix Therapeutics

Biotech firm developing mRNA-degrading therapies

Remix Therapeutics develops medicines for rare diseases by using targeted degradation of mRNA with an oral small molecule. Its lead candidate REM 422 degrades messenger RNA to stop production of disease-causing proteins and is in Phase 1 trials for ACC and AML, with FDA Orphan Drug designation. The company funds R&D through grants, partnerships, and eventual commercialization, leveraging collaborations with larger pharma. Its goal is to deliver safe and effective medicines for rare cancers and genetic disorders by advancing REM 422 and expanding its portfolio to address unmet medical needs.

Company size
51-200
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2018

Recently Posted Jobs

Explore more opportunities at Remix Therapeutics

See more jobs